In addition to our leadership team, Cardurion has assembled a world-class group of cardiovascular disease experts and industry veterans to inform the cutting-edge science that advances our pipeline while guiding the clinical development, trial design, regulatory affairs and commercialization of our products.
Peter S. Lawrence, J.D.
President and CEO
Shota Ikeda, Ph.D.
Head, Cardurion Pharmaceuticals K.K.
Karen Lewis
Chief People Officer
Michael E. Mendelsohn, M.D.
Founder and Chief Strategy Officer
Steve Migausky
Chief Legal Officer
Marcia D. Moore, M.P.H.
Chief Operating Officer
Charlotte Newman
Chief Business & Operating Officer
Elizabeth Radcliffe
Chief Financial Officer
Howard K. Surks, M.D.
Chief Medical and Scientific Officer
Keith Gottesdiener, M.D.
President and CEO, Prime Medicine
Kenneth Novack
Investor and Director
This site uses cookies and third-party scripts to provide certain services. View Privacy Policy
